Prof. Berend Snijder, Prevision Medicine’s co-founder and Chairman, together with colleagues at Snijder Lab, received the award for “Biggest Technology Impact of the Year” at the Precision Medicine Awards 2025, for their groundbreaking work on pharmacoscopy.

This recognition is especially meaningful to Prevision Medicine as pharmacoscopy has been at the heart of their journey from the very beginning. It powers their platform PrevisionOne and Prevision Medicine’s drug-screening tests – enabling more targeted, personalized, and guided treatments for patients.